首页 | 本学科首页   官方微博 | 高级检索  
     

地黄提取物的急性毒性和亚慢性毒性试验研究
引用本文:刘佳,李强,郭莉,李国辉,赵兴华,刘静,何欣. 地黄提取物的急性毒性和亚慢性毒性试验研究[J]. 中国畜牧兽医, 2017, 44(11): 3372-3378. DOI: 10.16431/j.cnki.1671-7236.2017.11.037
作者姓名:刘佳  李强  郭莉  李国辉  赵兴华  刘静  何欣
作者单位:1. 河北农业大学动物医学院, 保定 071000;
2. 保定市冀农动物药业有限公司, 保定 071000
基金项目:河北省现代农业产业技术体系蛋鸡产业创新团队项目(HBCT2013090202)
摘    要:试验通过考察地黄提取物的急性毒性和亚慢性毒性,评价其安全性,为临床用药提供理论依据。急性毒性试验采用昆明种小鼠进行半数致死量(LD50)和最大给药量(MTD)的测定。亚慢性毒性选取80只SD大鼠,分为低、中、高地黄提取物组和对照组,连续灌胃30 d,试验结束后进行血液常规和血液生化指标检测,处死后测定脏器系数,并做病理组织学观察。急性毒性试验结果显示,在试验期内未发现小鼠死亡,未测得LD50,小鼠最大给药量为61.54 g/kg。亚慢性毒性结果显示,各给药组大鼠的体重、血液生化指标、脏器系数及内脏组织病理学观察与对照组均无显著差异(P>0.05),未见与药物作用有关的病理变化。结果表明,在本试验条件下,根据世界卫生组织(WTO)有关外源性化学物急性毒性分级标准,地黄提取物属实际无毒物质,结合急性毒性和亚慢性毒性试验结果,说明按临床剂量使用地黄提取物是安全无毒的。

关 键 词:地黄提取物  急性毒性  亚慢性毒性  安全性  
收稿时间:2017-03-11

Study on Acute Toxicity and Sub-chronic Toxicity of the Extract of Rehmannia glutinosa
LIU Jia,LI Qiang,GUO Li,LI Guo-hui,ZHAO Xing-hua,LIU Jing,HE Xin. Study on Acute Toxicity and Sub-chronic Toxicity of the Extract of Rehmannia glutinosa[J]. China Animal Husbandry & Veterinary Medicine, 2017, 44(11): 3372-3378. DOI: 10.16431/j.cnki.1671-7236.2017.11.037
Authors:LIU Jia  LI Qiang  GUO Li  LI Guo-hui  ZHAO Xing-hua  LIU Jing  HE Xin
Affiliation:1. College of Veterinary Medicine, Hebei Agricultural University, Baoding 071000, China;
2. Baoding Jinong Animal Pharmaceutical Co., Ltd., Baoding 071000, China
Abstract:The purpose of this experiment was to study the acute toxicity and long-term sub-chronic toxicity of the extract of Rehmannia glutinosa in mice, evaluate the clinical safety of medication and provide theoretical basis for clinical application. Mice were chosen to measure the median lethal dose (LD50) and maximal tolerance dose (MTD). In the sub-chronic toxicity test, 80 SD rats were divided into four groups:Low dose, middle dose, high dose test groups with the extract of Rehmannia glutinosa and control group with normal saline for 30 d. On the 31th day, the rats were killed and the blood routine index, biochemistry index and the organ coefficient were measured. The MTD was 61.54 g/kg, according to the judgmental standard of the acute toxicity, the extract of Rehmannia glutinosa was safe. The sub-chronic toxicity test results showed that there were no significant difference in body weight and blood chemistry indexes and organ coefficient among the four groups (P>0.05) and there were no pathological change because of the medication. The result indicated that the extract of Rehmannia glutinosa was no acute toxicity under the condition of this test according to acute toxicity classification standard of exogenous by WTO, and it was no sub-chronic toxicity too, which suggested the extract had a good clinical safety.
Keywords:extract of Rehmannia glutinosa  acute toxicity  sub-chronic toxicity  safety  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国畜牧兽医》浏览原始摘要信息
点击此处可从《中国畜牧兽医》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号